Home βΊ Calculator βΊ ACRS Dividend Calculator 2026
ACRS Dividend Calculator 2026
No dividendHealthcareAclaris Therapeutics, Inc. Β· NASDAQ
Price: $3.79 Β· Annual div: None Β· Frequency: β Β· Payout ratio: N/A Β· Ex-div: β
Calculator settings
ACRS is not a dividend-focused stock
ACRS pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
ACRS Dividend Yield
Aclaris Therapeutics, Inc. (ACRS) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
π‘ What-if scenarios
Click to apply scenario to the calculator
π― When ACRS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Aclaris Therapeutics, Inc. (ACRS) β Dividend Analysis 2026
Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial unmet needs in immuno-inflammatory disorders; and the Contract Research segment, which delivers specialized laboratory services. The company's pipeline features several investigational compounds. Among these is Zunsemetinib, an MK2 inhibitor, being developed to treat moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, and hidradenitis suppurativa. Another significant candidate is ATI-1777, a soft JAK 1/3 inhibitor, intended for the management of moderate to severe atopic dermatitis. Additionally, Aclaris is advancing ATI-2138, an ITK/TXK/JAK3 inhibitor, as a potential intervention for T cell-mediated autoimmune diseases; a Gut-Biased Program targeting inflammatory bowel disease; and ATI-2231, an MK2 inhibitor, for the treatment of pancreatic and metastatic breast cancer. Established in 2012, Aclaris Therapeutics, Inc. has its corporate headquarters situated in Wayne, Pennsylvania.
ACRS Dividend & DRIP β Frequently Asked Questions
Does ACRS pay a dividend?
No. Aclaris Therapeutics, Inc. (ACRS) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of ACRS?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does ACRS have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. ACRS has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to ACRS
Forward dividend yield from the latest data Β· open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ACRS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ACRS position with:
π ACRS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ACRS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 0.00% | -2.80% | $0 / yr |
| πΊπΈ US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| π¬π§ UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| π¬π§ UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| π¨π¦ TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| π¨π¦ CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| π¦πΊ Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| π¦πΊ AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| π©πͺ DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| π«π· FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― ACRS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π ACRS Dividend Payment Schedule
ACRS pays quarterly β 4 times per year. Ex-div: β.
π ACRS vs Healthcare Benchmarks
How ACRS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ACRS sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ ACRS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-08-01 | 36,375 | β | β | ||
| M-Exempt | 2026-08-01 | 36,375 | β | β | ||
| F-InKind | 2026-08-01 | 12,385 | $5.20 | $64.4K | ||
| M-Exempt | 2026-06-05 | 11,580 | β | β | ||
| A-Award | 2026-06-04 | 42,350 | $4.71 | $199.5K | ||
| A-Award | 2026-06-04 | 42,350 | $4.71 | $199.5K | ||
| M-Exempt | 2026-06-05 | 11,580 | β | β | ||
| A-Award | 2026-06-04 | 10,987 | β | β | ||
| A-Award | 2026-06-04 | 10,987 | β | β | ||
| M-Exempt | 2026-06-05 | 11,580 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ACRS with peers: ACRS vs ALLO Β· ACRS vs BIOA Β· ACRS vs CABA
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ACRS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Aclaris Therapeutics, Inc. (ACRS) is currently trading at $3.79, 43% below its 52-week high. It does not currently pay a regular dividend.
Does ACRS Pay a Dividend? Aclaris Therapeutics, Inc. Dividend Status
Aclaris Therapeutics, Inc. (ACRS) is a healthcare stock trading at $3.79. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only β not financial advice.
Latest ACRS News
LiveProjected your ACRS DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.